JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2005) 184, 179-189    DOI: 10.1677/joe.1.05781
© 2005 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, A M
Right arrow Articles by Han, V K M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, A M
Right arrow Articles by Han, V K M

Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs

A M Carter1,2, M J Kingston1, K K Han1, D M Mazzuca1, K Nygard1 and V K M Han1,3

1 Child Health Research Institute, University of Western Ontario, London, Ontario N6C 2V5, Canada
2 Department of Physiology and Pharmacology, University of Southern Denmark, Winsløwparken 21, DK-5000 Odense, Denmark
3 Departments of Paediatrics, Obstetrics and Gynaecology, Biochemistry, Anatomy and Cell Biology, CIHR Group in Fetal and Neonatal Health and Development, Child Health Research Institute, London, Ontario N6A 4GS, Canada

(Requests for offprints should be addressed to V K M Han; Email: vhan{at}uwo.ca)

The IGF system is one of the most important endocrine and paracrine growth factor systems that regulate fetal and placental growth. We hypothesized that intrauterine growth restriction (IUGR) in guinea pigs is mediated by the altered expression of IGFs and/or IGF binding protein (BP) mRNAs in tissues and is related to growth of specific tissues. IUGR was induced by unilateral uterine artery ligation on day 30 of gestation, and fetal plasma, amniotic fluid and tissue samples were collected at 55–57 days (term about 68 days) from paired IUGR and control fetuses (n=6). Western ligand blotting and immunoblotting were used to compare IGFBP levels in plasma and amniotic fluid. Total RNA was extracted from placenta and fetal tissues, and the relative abundance of IGF-II and IGFBP-1–6 mRNA was determined by Northern blotting, using species-specific probes where available. IUGR fetuses had decreased (P<0.01, by Student’s t-test) placental weight and body weight with an increase in the brain:liver weight ratio. The principal IGFBPs in fetal plasma migrated at 40–35, 30 and 25 kDa and were identified as IGFBP-3, -2 and -4 respectively. IUGR was associated with elevated plasma IGFBP-2 and IGFBP-4 and reduced IGFBP-3 levels. IGFBPs were detected at low levels in amniotic fluid of control fetuses but at higher levels in IUGR fetuses. In IUGR placentae, there was a small increase in IGFBP-4 mRNA (P<0.05). IGFBP-2 mRNA increased (P<0.001) in liver of IUGR fetuses. IGF-II and IGFBP mRNA expression did not change in fetal muscle. The results are consistent with reduced IGF action, directly or through inhibition by IGFBPs, particularly by circulating and tissue IGFBP-2, as a potential causal factor in decreased growth of the placenta and certain fetal tissues.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. M. Carter
Maintaining the integrity of trophoblast during growth of the placenta. Focus on "Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta"
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1303 - C1304.
[Full Text] [PDF]


Home page
Hum ReprodHome page
W.-H. Zhou, M.-R. Du, L. Dong, X.-Y. Zhu, J.-Y. Yang, Y.-Y. He, and D.-J. Li
Cyclosporin A increases expression of matrix metalloproteinase 9 and 2 and invasiveness in vitro of the first-trimester human trophoblast cells via the mitogen-activated protein kinase pathway
Hum. Reprod., October 1, 2007; 22(10): 2743 - 2750.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. E Street, P. Seghini, S. Fieni, M. A. Ziveri, C. Volta, D. Martorana, I. Viani, D. Gramellini, and S. Bernasconi
Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls.
Eur. J. Endocrinol., October 1, 2006; 155(4): 567 - 574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. H. Bloomfield, P. L. van Zijl, M. K. Bauer, H. H. Phua, and J. E. Harding
Effect of pulsatile growth hormone administration to the growth-restricted fetal sheep on somatotrophic axis gene expression in fetal and placental tissues
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E333 - E339.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S Shaikh, F H Bloomfield, M K Bauer, H H Phua, R S Gilmour, and J E Harding
Amniotic IGF-I supplementation of growth-restricted fetal sheep alters IGF-I and IGF receptor type 1 mRNA and protein levels in placental and fetal tissues
J. Endocrinol., July 1, 2005; 186(1): 145 - 155.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society for Endocrinology.